Nervonik secures $52.5 million in Series B funding led by Amzak Health to enhance its peripheral nerve stimulation therapy development.
Amount Raised
$52.5 Million
Round Type
Series B
Los AngelesBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
Nervonik, Inc. has announced the closing of an oversubscribed $52.5 million Series B financing round. This funding will support the development and commercialization of its peripheral nerve stimulation system. The round was led by Amzak Health, with participation from several other investors
Quick answer
Nervonik raised $52.5 Million in a Series B round, dated April 27, 2026. Investors: Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, Shangbay Capital and Amzak Health. Nervonik is based in Los Angeles, California, United States.
- How much did Nervonik raise?
- Nervonik raised $52.5 Million in a Series B round on April 27, 2026.
- Who invested in Nervonik?
- Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, Shangbay Capital and Amzak Health are named as investors in this round.
- What does Nervonik do?
- Nervonik is a medical device company developing cutting-edge peripheral nerve stimulation (PNS) solutions to treat chronic pain.
- Where is Nervonik based and how big is it?
- Nervonik is based in Los Angeles, California, United States. Fundz records about 4 employees.
- Who are the decision-makers at Nervonik?
- Fundz holds 2 contacts at Nervonik, including the Sr. Director of Engineering and Supply Chain. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Nervonik that raised within 45 days of this round, from Fundz verified event records.
- ThruFlo Endovascular raised an undisclosed amount (Seed) on June 11, 2026.
- Uncovr raised $7M (Seed) on June 10, 2026.
- FesariusTherapeutics raised $20M (Series A) on June 10, 2026.
- NVENTRIC raised $23M on June 10, 2026.
- Flyte Aviation, Inc. raised $1M (Post-IPO Equity) on June 7, 2026.
- Veritas Aortic Solutions raised $12M (Seed) on June 1, 2026.
Who to call at Nervonik, and when
A new round usually means Nervonik is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nervonik raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nervonik, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nervonik. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nervonik raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNervonik raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.